BlueRock’s CEO on the Parkinson’s cell therapy data that was presented today at #MDSCongress
- blonca9
- Aug 28, 2023
- 1 min read
Seth Ettenberg describes safety, imaging, and efficacy takeaways from the 12-patient study.
Also look for unique social pages for BiotechTV U.
Genezen is a contract development and manufacturing organization (CDMO) with unique technical expertise in lentiviral, retroviral, and adeno-associated viral vectors. Offering process development, GMP viral vector manufacturing, and analytics, we are dedicated to helping you deliver safe, pure, and potent advanced therapies to the patients who need them.